PETQ Stock Overview
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally.
PetIQ, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$6.90|
|52 Week High||US$27.09|
|52 Week Low||US$6.85|
|1 Month Change||-26.12%|
|3 Month Change||-61.04%|
|1 Year Change||-72.94%|
|3 Year Change||-74.85%|
|5 Year Change||-73.08%|
|Change since IPO||-70.41%|
Recent News & Updates
PetIQ gains 1.84 % on $30M stock repurchase program
PetIQ (NASDAQ:PETQ) to repurchase up to $30M in aggregate of the company's outstanding shares of common stock. “We have confidence in PetIQ’s business model, financial strength, and future growth opportunities which we believe are undervalued in the Company’s current share price. We will use our cash on hand and free cash flow to repurchase stock and pay down debt while continuing to maintain the flexibility to pursue all strategic initiatives as part of our plan to create long-term shareholder value.” said Cord Christensen, PetIQ’s Chairman and Chief Executive Officer. Shares +1.84% premarket
PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|PETQ||US Healthcare||US Market|
Return vs Industry: PETQ underperformed the US Healthcare industry which returned 9.1% over the past year.
Return vs Market: PETQ underperformed the US Market which returned -21.5% over the past year.
|PETQ Average Weekly Movement||9.6%|
|Healthcare Industry Average Movement||8.0%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: PETQ is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: PETQ's weekly volatility (10%) has been stable over the past year.
About the Company
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications.
PetIQ, Inc. Fundamentals Summary
|PETQ fundamental statistics|
Is PETQ overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PETQ income statement (TTM)|
|Cost of Revenue||US$736.30m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.49|
|Net Profit Margin||-1.53%|
How did PETQ perform over the long term?See historical performance and comparison